Objectives To identify overall disease course, progression patterns and risk factors
predictive for progressive interstitial lung disease (ILD) in patients with systemic sclerosis …

Objective To assess survival and identify predictors of survival in patients with systemic
sclerosis-interstitial lung disease (SSc-ILD) who participated in the Scleroderma Lung …

Objectives To identify the predictive clinical characteristics and establish a prediction model
for the progression of mild interstitial lung disease (ILD) in patients with systemic sclerosis …

Background Interstitial lung disease in systemic sclerosis (SSc-ILD) is a major cause of SSc-
related death. Imunosuppressive treatment (IS) is used in patients with SSc for various organ …

Treatment for systemic sclerosis-associated interstitial lun... : Current Opinion in
Rheumatology Treatment for systemic sclerosis-associated interstitial lung disease : Current …

Objective To determine the prognostic value of pulmonary function test (PFT) trends at 1 and
2 years in interstitial lung disease (ILD) associated with systemic sclerosis (SSc). Methods …

Objective Patients with systemic sclerosis–associated interstitial lung disease (SSc‐ILD) are
thought to have the greatest decline in lung function (forced vital capacity [FVC]% predicted) …

Objective. Clinically meaningful change in systemic sclerosis (SSc) related interstitial lung
(SSc-ILD) disease is unknown. The aim of this study was to quantify change in pulmonary …

Objective Systemic sclerosis (SSc) carries a high risk of progressive interstitial lung disease
(ILD), but tools for stratifying individual risk are scarce. The purpose of this study was to …

Objectives To evaluate the clinical characteristics of patients with interstitial lung disease
(ILD) in the setting of a large cohort of systemic sclerosis (SSc) patients, and to analyse the …